NYSE · BRK-B
Berkshire Hathaway Inc.
$541.96+$1.62 (+0.3%)
Berkshire Hathaway Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.45% below the high.
Loading market information…
NASDAQ · TRUP · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Trupanion, Inc.’s quoted price sits in the lower half of its reported 52-week range, 35.74% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Trupanion, Inc.’s next earnings report is currently expected on Nov 5, 2026, with estimated earnings per share of $0.16. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Trupanion, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Trupanion, Inc. provides monthly subscription-based medical insurance for canine and feline companions across the United States, Canada, Puerto Rico, and Australia. The company's operations are divided into two main categories: Subscription Business and Other Business, serving both pet owners and veterinary professionals. Founded in 2000, the Seattle, Washington-headquartered firm was previously known as Vetinsurance International, Inc., before adopting the Trupanion, Inc. name in 2013.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:10 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 |
|---|
| May 1, 2025 |
| -$0.03+25.0% vs estimate |
| $341.98M-1.28% vs estimate |
| Q4 2024 | Feb 19, 2025 | $0.04-33.33% vs estimate | $337.31M+0.57% vs estimate |
|---|
| Q3 2024 | Oct 30, 2024 | $0.03+150.0% vs estimate | $327.46M-1.92% vs estimate |
|---|
THE ANALYST VIEW
15 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 4 contributors · Median target $31.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$541.96+$1.62 (+0.3%)
Berkshire Hathaway Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.45% below the high.
$343.58+$4.28 (+1.26%)
JPMorgan Chase & Co.’s quoted price sits in the upper half of its reported 52-week range, 6.25% below the high.
$410.54+$9.94 (+2.48%)
Visa Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.98% below the high.
$635.70+$25.39 (+4.16%)
Mastercard Incorporated’s quoted price sits in the upper half of its reported 52-week range, 0.91% below the high.
$51.14+$0.29 (+0.57%)
Bank of America Corporation’s quoted price sits in the lower half of its reported 52-week range, 21.6% below the high.
$190.00-$0.13 (-0.07%)
Morgan Stanley’s quoted price sits in the lower half of its reported 52-week range, 18.19% below the high.
$927.73+$2.56 (+0.28%)
The Goldman Sachs Group, Inc.’s quoted price sits in the lower half of its reported 52-week range, 19.61% below the high.
$84.81+$1.14 (+1.36%)
Wells Fargo & Company’s quoted price sits in the lower half of its reported 52-week range, 13.25% below the high.
